Setara Biosciences Raises $90 Million Series A To Advance Rare Disease Precision Medicines
· pulse2.com · popularity 19/100 · 0 similar stories today · Genetics, Genomics & Biotech (Science)
Read the original at pulse2.com →
Summary
Setara Biosciences has raised $90 million in Series A financing to advance a pipeline of precision medicines targeting rare genetic diseases and potentially broader indications. The post Setara Biosciences Raises $90 Million Series A To Advance Rare Disease Precision Medicines appeared first on Pulse 2.0 .
Found in: Pulse 2.0. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 8.